Citius Pharmaceuticals, Inc. — Investor Relations & Filings
Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company that develops and commercializes critical care products. The company's diversified pipeline focuses on anti-infectives in adjunct cancer care, stem cell therapies, and prescription products. Its portfolio includes LYMPHIR™, an FDA-approved therapy for adult patients with relapsed or refractory cutaneous T-cell lymphoma (CTCL). Key product candidates in development include Mino-Lok®, an antibiotic lock solution intended to treat patients with catheter-related bloodstream infections, and Halo-Lido, a topical formulation for the treatment of hemorrhoids. Additionally, the company is advancing a stem cell therapy platform for conditions such as acute respiratory distress syndrome (ARDS).
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| QUARTERLY REPORT | 2025-02-14 | English | |
| CURRENT REPORT | 2025-02-06 | English | |
| AMENDMENT NO. 1 TO FORM 10-K | 2025-01-27 | English | |
| FORM ARS | 2025-01-27 | English | |
| DEFINITIVE ADDITIONAL MATERIALS | 2025-01-27 | English | |
| DEFINITIVE PROXY STATEMENT | 2025-01-27 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
10 filings
| |||||
| 12405959 | QUARTERLY REPORT | 2025-02-14 | English | ||
| 12405958 | CURRENT REPORT | 2025-02-06 | English | ||
| 12405960 | AMENDMENT NO. 1 TO FORM 10-K | 2025-01-27 | English | ||
| 12405962 | FORM ARS | 2025-01-27 | English | ||
| 12405961 | DEFINITIVE ADDITIONAL MATERIALS | 2025-01-27 | English | ||
| 12405969 | DEFINITIVE PROXY STATEMENT | 2025-01-27 | English | ||
| 12405964 | PRELIMINARY PROXY STATEMENT | 2025-01-16 | English | ||
| 12405963 | CURRENT REPORT | 2025-01-08 | English | ||
| 12405967 | PROSPECTUS SUPPLEMENT | 2025-01-08 | English | ||
| 12405965 | CURRENT REPORT | 2025-01-07 | English | ||
|
2024
5 filings
| |||||
| 12405966 | CURRENT REPORT | 2024-12-27 | English | ||
| 12405968 | ANNUAL REPORT | 2024-12-27 | English | ||
| 12405973 | FORM 8-K | 2024-12-20 | English | ||
| 12405970 | AMENDMENT NO. 2 TO SCHEDULE 13D | 2024-11-27 | English | ||
| 12405971 | CURRENT REPORT | 2024-11-26 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Citius Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34965/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34965 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34965 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34965 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34965}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Citius Pharmaceuticals, Inc. (id: 34965)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.